Patent Applications published on Feb 26, 2026 - page 3

#601
US20260053680A1
Human necessities

ABSORBENT ARTICLE WITH LAMINATE BOND PATTERN

#602
US20260053681A1
Human necessities

ABSORBENT ARTICLE WITH WAISTBAND

#603
US20260053682A1
Human necessities

MOBILE HOSPITAL WITH MODULAR STORAGE AND DEPLOYMENT

#604
US20260053683A1
Human necessities

WHEELCHAIR LOCATION SENSING DEVICE FOR A WHEELCHAIR ACCESSIBLE VEHICLE

#605
US20260053684A1
Human necessities

Patient Transport Apparatus For Traversing Stairs

#606
US20260053685A1
Human necessities

ASSISTANCE DEVICE EQUIPPED WITH HANDLE AND MOVEMENT DEVICE USING SAME

#607
US20260053686A1
Human necessities

Bed Assist Rail

#608
US20260053687A1
Human necessities

PRESSURE-MITIGATION APPARATUSES DESIGNED FOR PARTIAL AND FULL BODY USE

#609
US20260053688A1
Human necessities

DYNAMIC HALO GRAVITY TRACTION SYSTEM AND METHOD

#610
US20260053689A1
Human necessities

ARM SUPPORTING MECHANISM AND UPPER LIMB REHABILITATION ROBOT

#611
US20260053690A1
Human necessities

HAND TRAINING APPARATUS

#612
US20260053691A1
Human necessities

Mobility Support Apparatus

#613
US20260053692A1
Human necessities

POWERED WALKING ASSISTANCE DEVICE WITH CANE PORTION USED AS JOYSTICK CONTROLLER

#614
US20260053693A1
Human necessities

ADJUSTABLE-LENGTH LIMB-COMPRESSION DEVICE

#615
US20260053694A1
Human necessities

ARMREST MECHANISM AND MASSAGE MACHINE

#616
US20260053695A1
Human necessities

DRIVING METHOD OF THERMAL MASSAGE DEVICE FOR STRENGTHENING IMMUNITY

#617
US20260053696A1
Human necessities

MASSAGER WITH SWING STRUCTURE

#618
US20260053697A1
Human necessities

HEAD-WORN SEXUAL MASSAGER

#619
US20260053698A1
Human necessities

MASSAGE DEVICE WITH SYMMETRICAL MOTOR ARRANGEMENT

#620
US20260053699A1
Human necessities

Massage gun with Handle Extension Function

#621
US20260053700A1
Human necessities

STICK-SLIP FRICTIONAL SWIVEL COUPLING FOR A MASSAGE TOOL RECIPROCATED AT FORCED FREQUENCY

#622
US20260053701A1
Human necessities

APPARATUS HAVING A VIBRATION FUNCTION, IN PARTICULAR SHOWER HEAD HAVING A VIBRATION FUNCTION

#623
US20260053702A1
Human necessities

MECHANICAL CPR DEVICE WITH CHEST-HEIGHT SENSOR

#624
US20260053703A1
Human necessities

HOT AND COLD IMMERSION TUB AND TEMPERATURE CONTROL SYSTEM THEREFOR

#625
US20260053704A1
Human necessities

SYSTEMS AND METHODS FOR ICE BATH TEMPERATURE CONTROL AND MANAGEMENT

#626
US20260053705A1
Human necessities

ACUPRESSURE DEVICES

#627
US20260053706A1
Human necessities

LOCK TO POLE BIOMETRIC ACCESS INTRAVENEOUS MEDICATION LOCKBOX

#628
US20260053707A1
Human necessities

CENTRIFUGAL MEDICINE MIXER DEVICE AND RELATED METHODS

#629
US20260053708A1
Human necessities

PILL-CUTTER-AND-GRINDER

#630
US20260053709A1
Human necessities

CHILD RESISTANT AND AIRTIGHT CONTAINER

#631
US20260053710A1
Human necessities

WORK STATIONS FOR PREPARATION OF MEDICAL DOSES

#632
US20260053711A1
Human necessities

SEMI-SOLID PHARMACEUTICAL COMPOSITION MICRO-DISPENSER

#633
US20260053712A1
Human necessities

PHYSICIAN SYSTEM AND METHOD FOR INTERFACING WITH AND CONTROLLING A MEDICATION DISPENSING DEVICE

#634
US20260053713A1
Human necessities

SMART PILLBOX

#635
US20260053714A1
Human necessities

CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL

#636
US20260053715A1
Human necessities

DENTAL ADHESIVE COMPOSITION

#637
US20260053716A1
Human necessities

COMPOSITION FOR DENTIN ADHESION AND COMPOSITION FOR PULP RESTORATION, EACH COMPOSITION CONTAINING CPNE7-DERIVED PEPTIDE

#638
US20260053717A1
Human necessities

CARIOUS TOOTH STRUCTURE RECOVERY AGENT, AND DENTAL ADHESIVE KIT

#639
US20260053718A1
Human necessities

POWDER DETERGENT

#640
US20260053719A1
Human necessities

BABY WASH/SHAMPOO

#641
US20260053720A1
Human necessities

GRAPHENE OXIDE-BASED COMPOSITION FOR PREVENTING OR ALLEVIATING HAIR LOSS

#642
US20260053721A1
Human necessities

SILICONE PARTICLES FOR COSMETICS, AND COSMETICS

#643
US20260053722A1
Human necessities

Solid Compositions Containing Amine, Protonated Amine or Quaternary Ammonium Compounds

#644
US20260053723A1
Human necessities

PLAQUE DISCLOSING COMPOSITION

#645
US20260053724A1
Human necessities

ORAL CARE COMPOSITIONS

#646
US20260053725A1
Human necessities

COSMETIC PREPARATION CONTAINING CROSSLINKED ORGANIC SILICON RESIN AND METHOD FOR PRODUCING SAME

#647
US20260053726A1
Human necessities

ODOR ELIMINATING COMPOSITION

#648
US20260053727A1
Human necessities

PERSONAL CARE COMPOSITIONS WITH ENZYME-MODIFIED OILS (EMOS)

#649
US20260053728A1
Human necessities

Topical Hair Growth Oil Compound

#650
US20260053729A1
Human necessities

HEMOPEXIN FORMULATIONS

#651
US20260053730A1
Human necessities

SEMIFLUORINATED ALKANE TETRACYCLINE COMBINATION COMPOSITIONS FOR TREATMENT OF MALAR EDEMA

#652
US20260053731A1
Human necessities

MICRONEEDLE PARTICLES FOR ENHANCED TOPICAL TRANSDERMAL DRUG DELIVERY

#653
US20260053732A1
Human necessities

DEVICE FOR MAINTAINING METAL HOMEOSTASIS, AND USES THEREOF

#654
US20260053733A1
Human necessities

IMPLANTABLE POLYMER DEPOTS FOR THE CONTROLLED RELEASE OF THERAPEUTIC AGENTS

#655
US20260053734A1
Human necessities

METHODS OF FABRICATING THERMOSENSITIVE HYDROGELS AND USES THEREOF FOR INDUCING CHRONIC GLAUCOMA ANIMAL MODELS

#656
US20260053735A1
Human necessities

OCULAR HYDROGEL TYROSINE KINASE INHIBITOR IMPLANTS

#657
US20260053736A1
Human necessities

LONG ACTING DRUG DELIVERY DEVICE AND ITS USE IN CONTRACEPTION

#658
US20260053737A1
Human necessities

METHODS AND COMPOSITIONS FOR SUSTAINED RELEASE MICROPARTICLES FOR OCULAR DRUG DELIVERY

#659
US20260053738A1
Human necessities

USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS

#660
US20260053739A1
Human necessities

PRESSURIZED INHALATION COMPOSITION OF TIOTROPIUM

#661
US20260053740A1
Human necessities

PREPARATION FOR BIONIC INJECTABLE POLYPEPTIDE HYDROGEL AND USE THEREOF

#662
US20260053741A1
Human necessities

HYDROGEL COMPRISING GLYCEROL AND A CARBOMER FOR TREATING THE RESPIRATORY SYMPTOMS OF COVID-19 DISEASE VIA THE NASAL ROUTE

#663
US20260053742A1
Human necessities

FORMULATIONS COMPRISING G-CSF AND USES THEREOF

#664
US20260053743A1
Human necessities

TOPICAL SKIN FORMULATIONS OF A PHARMACEUTICALLY ACCEPTABLE SALT OF RUXOLITINIB

#665
US20260053744A1
Human necessities

NANODELIVERY SYSTEMS FOR EXTENDED RELEASE OF ANTIBODIES

#666
US20260053745A1
Human necessities

METHODS OF PROPHYLAXIS OF CORONAVIRUS INFECTION AND TREATMENT OF CORONAVIRUSES

#667
US20260053746A1
Human necessities

COMPOSITIONS AND METHODS OF USE THEREOF FOR PREVENTION OF MASTITIS

#668
US20260053747A1
Human necessities

RECONSTITUTED HIGH-DENSITY LIPOPROTEIN NANOPARTICLES COMPRISING CHOLESTEROL

#669
US20260053748A1
Human necessities

NOVEL METHODS

#670
US20260053749A1
Human necessities

MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF

#671
US20260053750A1
Human necessities

INHALABLE COMPOSITIONS OF CDK9 INHIBITORS

#672
US20260053751A1
Human necessities

Dry Powdered Formulations

#673
US20260053752A1
Human necessities

Thermo-Sensitive Electrolyte Supplement with Delayed Release for Enhanced Hydration

#674
US20260053753A1
Human necessities

A DELIVERY SYSTEM COMPRISING SILICON-CONTAINING MATERIAL

#675
US20260053754A1
Human necessities

KAEMPFEROL BIOMIMETIC NANO-MATERIAL, METHOD FOR PREPARING SAME AND USE THEREOF

#676
US20260053755A1
Human necessities

PHARMACEUTICAL COMPOSITIONS FOR USE IN TREATING OBSTRUCTIVE SLEEP APNEA

#677
US20260053756A1
Human necessities

DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR

#678
US20260053757A1
Human necessities

DOSAGE REGIME WITH ESKETAMINE FOR TREATING NEUROPSYCHIATRIC OR NEUROLOGICAL CONDITIONS

#679
US20260053758A1
Human necessities

COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS

#680
US20260053759A1
Human necessities

MESDOPETAM COMPOSITIONS

#681
US20260053760A1
Human necessities

Compositions Suitable for Use on Skin Afflicted with Eczema

#682
US20260053761A1
Human necessities

USE OF THYROMIMETICS FOR THE TREATMENT OF CANCER

#683
US20260053762A1
Human necessities

USE OF PDH INHIBITOR FOR TREATING NEUROPATHY

#684
US20260053763A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING RENAL CYSTIC CILIOPATHY

#685
US20260053764A1
Human necessities

COMPOSITION FOR PREVENTING DETERIORATION IN COGNITIVE FUNCTION AND/OR IMPROVING COGNITIVE FUNCTION

#686
US20260053765A1
Human necessities

COMPOSITIONS AND METHODS FOR THE IMPROVEMENT OF MEMORY

#687
US20260053766A1
Human necessities

(S)-2-AMINO-6-((3-AMINOPROPYL)AMINO)HEXANOIC ACID (APL) FOR USE IN THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH), LIVER INFLAMMATION, HEPATOCELLULAR BALLOONING, LIVER FIBROSIS AND STEATOSIS

#688
US20260053767A1
Human necessities

Hepatoprotective Compositions And Methods

#689
US20260053768A1
Human necessities

Sustained Nitric Oxide Releasing Drug Delivery Systems

#690
US20260053769A1
Human necessities

USES OF SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM) COMPOUNDS FOR QUALITY WEIGHT LOSS

#691
US20260053770A1
Human necessities

COMPOSITION AND METHOD FOR TREATING ARTHRITIS

#692
US20260053771A1
Human necessities

NUTRACEUTICAL COMPOSITIONS AND METHODS FOR USING SAME

#693
US20260053772A1
Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING B-LAPACHONE AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CHOLESTATIC LIVER DISEASE

#694
US20260053773A1
Human necessities

PHARMACEUTICAL COMPOSITION AND USE THEREOF

#695
US20260053774A1
Human necessities

PARENTERAL COMPOSITIONS OF ZILEUTON AND METHODS OF USE

#696
US20260053775A1
Human necessities

METHODS, COMPOSITIONS, KITS AND USES THEREOF TARGETING AND/OR TREATING VRK2 TO ENHANCE EFFECTIVENESS OF IMMUNE CHECKPOINT INHIBITOR(S)

#697
US20260053776A1
Human necessities

COMPOUNDS USEFUL FOR INHIBITING BFL1 AND THEIR USE IN THERAPY

#698
US20260053777A1
Human necessities

USE OF NRF2 ACTIVATORS FOR THE TREATMENT OF CEREBRAL SMALL VESSEL DISEASE

#699
US20260053778A1
Human necessities

USE OF NOVEL PPAR ACTIVITY MODULATOR FOR PREVENTION, AMELIORATION OR TREATMENT OF DEGENERATIVE BRAIN DISEASES

#700
US20260053779A1
Human necessities

COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES

#701
US20260053780A1
Human necessities

COMPOSITIONS, METHODS, AND SYSTEMS FOR TREATING PRESBYOPIA

#702
US20260053781A1
Human necessities

COMPOSITIONS, METHODS, AND SYSTEMS FOR TREATING PRESBYOPIA

#703
US20260053782A1
Human necessities

TREATMENT REGIMENS FOR PARKINSON'S DISEASE

#704
US20260053783A1
Human necessities

PIOGLITAZONE AND MEK INHIBITORS FOR TREATING CANCER

#705
US20260053784A1
Human necessities

METHOD OF TREATMENT WITH MILSAPERIDONE

#706
US20260053785A1
Human necessities

COMBINATION THERAPY FOR TREATMENT OF CANCER

#707
US20260053786A1
Human necessities

FORMULATIONS OF RADIPRODIL

#708
US20260053787A1
Human necessities

CYANO-SUBSTITUTED CYCLIC HYDRAZINE DERIVATIVE AND APPLICATION THEREOF

#709
US20260053788A1
Human necessities

METHODS AND COMPOSITIONS FOR MODULATING HEMOSTASIS AND METABOLIC HOMEOSTASIS DURING HEMORRHAGE

#710
US20260053789A1
Human necessities

TREATING ELEVATED INTRAOCULAR PRESSURE WITH NICOTINAMIDE

#711
US20260053790A1
Human necessities

TREATMENTS FOR CONDITIONS INVOLVING INCREASED IL-6 LEVELS

#712
US20260053791A1
Human necessities

USE OF TIVOZANIB TO TREAT SUBJECTS WITH REFRACTORY CANCER

#713
US20260053792A1
Human necessities

POLYSUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF

#714
US20260053793A1
Human necessities

USE OF BERBERINE DERIVATIVE NBD-125 IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING OBESITY

#715
US20260053794A1
Human necessities

SOMATOSTATIN RECEPTOR 2 AGONISTS AND USES THEREOF

#716
US20260053795A1
Human necessities

KETAMINE OR DEXTROMETHORPHAN FORMULATIONS AND METHODS OF USE

#717
US20260053796A1
Human necessities

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR

#718
US20260053797A1
Human necessities

METHOD AND FORMULATION FOR TREATING MALE PREMATURE EJACULATION

#719
US20260053798A1
Human necessities

COMBINATION THERAPY FOR A RAS RELATED DISEASE OR DISORDER

#720
US20260053799A1
Human necessities

COMPOUNDS FOR TREATING CANCER

#721
US20260053800A1
Human necessities

COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL

#722
US20260053801A1
Human necessities

METHOD FOR TREATING AUTOPHAGY DEPENDENT CANCER WITH A PIKFYVE INHIBITOR

#723
US20260053802A1
Human necessities

TREATMENT OF CANCER USING COMBINATION THERAPIES COMPRISING GDC-6036 and GDC-0077

#724
US20260053803A1
Human necessities

KINASE MUTANTS AND USES THEREOF

#725
US20260053804A1
Human necessities

Compositions and Methods for the Restoration of Ciliary Function

#726
US20260053805A1
Human necessities

XANTHINE OXIDASE INHIBITOR FORMULATIONS

#727
US20260053806A1
Human necessities

GAMMA POLYGLUTAMATED METHOTREXATE AND USES THEREOF

#728
US20260053807A1
Human necessities

ALPHA POLYGLUTAMATED AMINOPTERIN AND USES THEREOF

#729
US20260053808A1
Human necessities

NOVEL USES

#730
US20260053809A1
Human necessities

MOLECULAR THERAPEUTIC STRATEGY COMBINING IDELALISIB AND SRPIN340 TO TREAT ADVANCE SOLID TUMORS

#731
US20260053810A1
Human necessities

Time-Released Caffeine Sleep Aid with Dual-Phase Formulation for Improved Sleep and Wakefulness

#732
US20260053811A1
Human necessities

METHODS OF TREATING HYPERTENSION IN OBESE SUBJECTS

#733
US20260053812A1
Human necessities

METHODS OF TREATING HYPERTENSION WITH A COMBINATION OF AN ALDOSTERONE SYNTHASE INHIBITOR AND A DIURETIC

#734
US20260053813A1
Human necessities

Substituted Pyrazolo-Pyrimidines and Uses Thereof

#735
US20260053814A1
Human necessities

TREATMENT REGIMENS FOR GEDATOLISIB IN HORMONALLY-DRIVEN DISORDERS

#736
US20260053815A1
Human necessities

COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES

#737
US20260053816A1
Human necessities

MISOPROSTOL FORMULATION FOR BUCCAL ADMINISTRATION

#738
US20260053817A1
Human necessities

PROGESTOGEN-ONLY ORAL CONTRACEPTION

#739
US20260053818A1
Human necessities

PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CHANGES TO THE RECTUM

#740
US20260053819A1
Human necessities

TREATMENT OF DISEASES CAUSED BY RNA VIRUSES

#741
US20260053820A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TOPICAL ADMINISTRATION OF SPIRONOLACTONE FOR THE TREATMENT OF CUTANEOUS SIGNS OF EXCESS ANDROGEN AND CHRONIC STRESS RESPONSE

#742
US20260053821A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF SPIRONOLACTONE FOR DEEP DERMAL DRUG DELIVERY

#743
US20260053822A1
Human necessities

COMPOSITIONS OF GRAPIPRANT AND METHODS FOR USING THE SAME

#744
US20260053823A1
Human necessities

PREVENTATIVE MOUTHWASH CONTAINING A SUB-ANTIMICROBIAL ORAL DOSAGE OF DOXYCYCLINE, METHOD OF PREVENTING COVID INFECTION USING THE MOUTHWASH, AND METHOD OF FORMULATING THE MOUTHWASH

#745
US20260053824A1
Human necessities

SALTS AND POLYMORPHS OF A TETRACYCLINE COMPOUND

#746
US20260053825A1
Human necessities

CONSUMER PACKAGE FOR BITE TREATMENT CONTAINING A TOPICAL CREAM THAT INCLUDES A TETRACYCLINE OR THIRD GENERATION CEPHALOSPORIN

#747
US20260053826A1
Human necessities

FACE AND BODY OIL COMPOSITION

#748
US20260053827A1
Human necessities

Cannabidiol Solid Dosage Forms

#749
US20260053828A1
Human necessities

COMBINATION PREPARATIONS OF 3-N-FORMYLHYDROXYLAMINOPROPYL PHOSPHONIC ACID DERIVATIVES OR 3-N-ACETYLHYDROXYLAMINOPROPYL PHOSPHONIC ACID DERIVATIVES WITH CLINDAMYCIN AND ARTESUNATE

#750
US20260053829A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING COGNITIVE FUNCTION

#751
US20260053830A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING COGNITIVE FUNCTION

#752
US20260053831A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING COGNITIVE FUNCTION

#753
US20260053832A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING COGNITIVE FUNCTION

#754
US20260053833A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CARDIOMYOPATHIES

#755
US20260053834A1
Human necessities

COVALENT MODIFIERS OF AKT1 AND USES THEREOF

#756
US20260053835A1
Human necessities

Anti-Aging Formulation Comprising Human Milk Oligosaccharides, Ellagic Acid, and Probiotics to Enhance Urolithin A Production

#757
US20260053836A1
Human necessities

CHRONIC WOUND HEALING COMPOSITION AND APPLICATION THEREOF

#758
US20260053837A1
Human necessities

NICOTINAMIDE-RIBOSIDE AND PTEROSTILBENE COMBINATIONS TO TREAT OSTEOARTHRITIS

#759
US20260053838A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING SUBSTITUTED NUCLEOTIDES AND NUCLEOSIDES FOR TREATING VIRAL INFECTIONS

#760
US20260053839A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN (TTR) MEDIATED AMYLOIDOSIS

#761
US20260053840A1
Human necessities

COMPOSITION OF NOVEL CARBOHYDRATE DRUG FOR TREATMENT OF HUMAN DISEASES

#762
US20260053841A1
Human necessities

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

#763
US20260053842A1
Human necessities

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

#764
US20260053843A1
Human necessities

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

#765
US20260053844A1
Human necessities

COMPOSITIONS AND METHODS FOR WEIGHT LOSS AND SATIETY IMPROVEMENT

#766
US20260053845A1
Human necessities

LIPOSOMAL FORMULATION AND USE IN A COMBINATION PRODUCT AS AN ANTI-TUMOUR THERAPY

#767
US20260053846A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATMENT OF AMYLOID-RELATED DISORDERS

#768
US20260053847A1
Human necessities

HYDROGEN-GAS-CONTAINING DRUG FOR CAUSAL TREATMENT OF ALZHEIMER'S DISEASE (DISEASE-MODIFYING DRUG)

#769
US20260053848A1
Human necessities

ORAL FORMULATIONS COMPRISING POROUS SILICA PARTICLES AND MEDICAL USES THEREOF

#770
US20260053849A1
Human necessities

NEW IRON AND ACACIA GUM ORAL COMPOSITIONS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN IRON DEFICIENCY CONDITIONS

#771
US20260053850A1
Human necessities

ECM HYDROGEL FOR TREATING ESOPHAGEAL INFLAMMATION

#772
US20260053851A1
Human necessities

INDUCIBLE SYSTEMS FOR ALTERING GENE EXPRESSION IN HYPOIMMUNOGENIC CELLS

#773
US20260053852A1
Human necessities

NONCODING RNA AGENTS (BCYRN1 AND DERIVATIVES THEREOF) TO TREAT DISEASES OF IMMUNITY

#774
US20260053853A1
Human necessities

ENGINEERED T CELL RECEPTOR CONSTRUCTS FOR CANCER THERAPY

#775
US20260053854A1
Human necessities

ANTI-PSMA SINGLE-CHAIN ANTIBODY, CHIMERIC ANTIGEN RECEPTOR ASSOCIATED THEREWITH AND USE THEREOF

#776
US20260053855A1
Human necessities

Modified Cytotoxic T Cells and Methods of Use Thereof

#777
US20260053856A1
Human necessities

IMMUNOCOMPETENT CELL AND EXPRESSION VECTOR EXPRESSING REGULATORY FACTORS OF IMMUNE FUNCTION / A CELL SURFACE MOLECULE SPECIFICALLY RECOGNIZING HUMAN MESOTHELIN, IL-7 AND CCL19

#778
US20260053857A1
Human necessities

Compositions for Drug Delivery and Methods of Use Thereof

#779
US20260053858A1
Human necessities

COMPOSITIONS COMPRISING CELL-DELIVERED VESICLES AND USES THEREOF

#780
US20260053859A1
Human necessities

GENETICALLY ENGINEERED CELLS

#781
US20260053860A1
Human necessities

METHOD OF PROMOTING RETURN OF ESTRUS IN ANIMAL AND AGENT FOR PROMOTING RETURN TO ESTRUS IN ANIMAL

#782
US20260053861A1
Human necessities

CELL COMPOSITIONS AND METHODS OF USING THE SAME

#783
US20260053862A1
Human necessities

DEVICE FOR PROCESSING TISSUE

#784
US20260053863A1
Human necessities

ACELLULAR ALLOGENIC EXOSOME PREPARATIONS AND METHODS OF USE

#785
US20260053864A1
Human necessities

ANTI-OBESITY AGENT COMPRISING ENTEROBACTERIA AS ACTIVE INGREDIENT AND METHOD FOR PRODUCING SAME

#786
US20260053865A1
Human necessities

PRODUCT FOR THE TREATMENT OF DYSBIOSIS

#787
US20260053866A1
Human necessities

COMPOSITIONS FOR USE IN TREATING AND/OR PREVENTING TYPE 2 DIABETES, PRE-DIABETES, AND/OR A SYMPTOM THEREOF

#788
US20260053867A1
Human necessities

COMBINATION OF NON-VIABLE CELLS OF STREPTOCOCCUS PYOGENES AND IMMUNE CHECKPOINT INHIBITOR FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER AND NON-MUSCLE INVASIVE BLADDER CANCER

#789
US20260053868A1
Human necessities

METHOD OF USING A COMPOSITION COMPRISING A NOVEL STREPTOCOCCUS SALIVARIUS STRAIN IN PREVENTING OR ALLEVIATING AN ORAL DISEASE

#790
US20260053869A1
Human necessities

LACTOBACILLUS DELBRUECKII SUBSP. LACTIS CKDB001 STRAIN, AND COMPOSITION FOR PREVENTION, AMELIORATION, OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER COMPRISING SAME

#791
US20260053870A1
Human necessities

METHANOLYTIC AGENTS AND METHODS OF USING THE SAME

#792
US20260053871A1
Human necessities

A CARBOMER HYDROGEL COMPRISING A PHAGE LYSATE FOR MAINTAINING NATURAL SKIN MICROFLORA AND SUPPRESSING PATHOGENIC BACTERIA

#793
US20260053872A1
Human necessities

ADOPTIVE CELLULAR THERAPY

#794
US20260053873A1
Human necessities

COMBINATION THERAPY OF ONCOLYTIC VIRUS DRUGS FOR CANCER TREATMENT

#795
US20260053874A1
Human necessities

COMPOSITIONS AND METHODS TO IMPROVE SEQUESTRATION OF MYCOTOXINS AND THEIR USE IN DETOXIFICATION OF ANIMAL FEED AND ANIMAL PRODUCTION SYSTEMS

#796
US20260053875A1
Human necessities

TRANSDERMAL DRUG-CARRIER VEHICLE FOR TOPICAL, LYMPHATIC, MUSCULAR, AND SYSTEMIC DELIVERY OF BIOACTIVE ANDROGRAPHOLIDES, AND/OR EPIGALLOCATECHIN GALLATE

#797
US20260053876A1
Human necessities

COMPOSITIONS AND METHODS FOR PREVENTING, ALLEVIATING, OR TREATING LIVER DISEASE

#798
US20260053877A1
Human necessities

COMPOSITION FOR ALLEVIATING, PREVENTING OR TREATING KIDNEY DISEASE OR VASCULAR DISEASE COMPRISING PANAX GINSENG EXTRACTS FERMENTED BY LACTOBACILLUS PLANTARUM, AND PREPARATION METHOD THEREOF

#799
US20260053878A1
Human necessities

PROCESS FOR EXTRACTION OF ACTIVE COMPOUNDS FROM PLANT BIOMASS

#800
US20260053879A1
Human necessities

COMPOSITION COMPRISING CURCUMINOIDS, MODIFIED STARCH AND/OR ACACIA GUM AND SAPONINS FOR USE AS A MEDICAMENT

#801
US20260053880A1
Human necessities

Nrf2 activator and method for producing same

#802
US20260053881A1
Human necessities

Supplement Formulation for Enhanced Bioavailability of Turmeric Extract Focusing on Ease of Use

#803
US20260053882A1
Human necessities

LOGIC GATED PROTEIN ACTUATORS

#804
US20260053883A1
Human necessities

OXYTOCIN COMPOSITIONS FOR TREATMENT OF VISUAL SNOW SYNDROME

#805
US20260053884A1
Human necessities

PEPTIDE CONGENERS WITH POLYMER EXCIPIENTS

#806
US20260053885A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

#807
US20260053886A1
Human necessities

ANTICANCER AGENT

#808
US20260053887A1
Human necessities

Methods and Kits to Prevent And/Or Treat Cardiac Disorders

#809
US20260053888A1
Human necessities

GIP/GLP1 AGONIST COMPOSITIONS

#810
US20260053889A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES, DISORDERS, AND CONDITIONS

#811
US20260053890A1
Human necessities

Transgenic Corn With Antifungal Peptide AGM182 (DN:0113.18)

#812
US20260053891A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING CANCER

#813
US20260053892A1
Human necessities

Induction and Expansion of Regulatory T Cells

#814
US20260053893A1
Human necessities

ANAKINRA FOR THE TREATMENT OF POST ACUTE COVID SYNDROME

#815
US20260053894A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING DIABETES

#816
US20260053895A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND THEIR USES, AND METHODS FOR IMPROVING THE STORAGE STABILITY OF PHARMACEUTICAL COMPOSITIONS

#817
US20260053896A1
Human necessities

WOUND HEALING AND RELATED PRODUCTS AND METHODS THEREOF FOR REGULATING TISSUE GROWTH FACTORS FOR HEALING

#818
US20260053897A1
Human necessities

SUPEROXIDE DISMUTASE AND USES THEREOF FOR PREVENTING OR TREATING DIABETIC RETINOPATHY OR UVEITIS

#819
US20260053898A1
Human necessities

INTERLEUKIN-2 MUTANT AND FUSION PROTEIN THEREOF

#820
US20260053899A1
Human necessities

BIOMARKERS AND IMMUNOGENIC COMPOSITIONS FOR FILARIAL PARASITES

#821
US20260053900A1
Human necessities

USE OF VIRUS-LIKE PARTICLES IN VACCINATION

#822
US20260053901A1
Human necessities

ANTIGEN COMPOSITION, COMPOSITION FOR ANTIGEN EXPRESSION, AND ANTIBODY COMPOSITION

#823
US20260053902A1
Human necessities

COMPOSITIONS AND METHODS FOR REDUCING THE RATE OF TYPE 1 DIABETES

#824
US20260053903A1
Human necessities

COMPOSITIONS AND METHODS FOR TARGETING DENDRITIC CELL LECTINS

#825
US20260053904A1
Human necessities

CONDITIONALLY ACTIVE ANTI-EPCAM ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUGATES AND USES THEREOF

#826
US20260053905A1
Human necessities

UVEAL MELANOMA VACCINE

#827
US20260053906A1
Human necessities

DNA ORIGAMI VACCINES

#828
US20260053907A1
Human necessities

METHOD OF ADMINISTRATION OF AQUACULTURE VACCINES

#829
US20260053908A1
Human necessities

Vaccines For Recurrent Respiratory Papillomatosis And Methods Of Using The Same

#830
US20260053909A1
Human necessities

GENOMIC VARIANTS IN IG GENE REGIONS AND USES OF SAME

#831
US20260053910A1
Human necessities

HBV VACCINES AND METHODS TREATING HBV

#832
US20260053911A1
Human necessities

PYRIMIDINE COMPOUND

#833
US20260053912A1
Human necessities

STEROLS AS NOVEL IMMUNOMODULATORY AGENTS AND THEIR USE AS VACCINE ADJUVANTS

#834
US20260053913A1
Human necessities

COMBINATIONS OF CTLA4 BINDING PROTEINS AND METHODS OF TREATING CANCER

#835
US20260053914A1
Human necessities

METHODS OF USING ANTI-PSGL-1 ANTIBODIES IN COMBINATION WITH JAK INHIBITORS TO TREAT T-CELL MEDIATED INFLAMMATORY DISEASES OR CANCERS

#836
US20260053915A1
Human necessities

COMBINATION OF RADIATION/CHEMOTHERAPY, PD-1 INHIBITOR AND FATTY ACID SYNTHASE INHIBITOR

#837
US20260053916A1
Human necessities

METHODS AND COMPOSITIONS RELATING TO TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

#838
US20260053917A1
Human necessities

TREATMENT METHOD

#839
US20260053918A1
Human necessities

Use of Triplex CMV Vaccine in CAR T Cell Therapy

#840
US20260053919A1
Human necessities

PHARMACEUTICAL PRODUCTS AND STABLE LIQUID COMPOSITIONS OF IL-17 ANTIBODIES

#841
US20260053920A1
Human necessities

NOVEL TCRs

#842
US20260053921A1
Human necessities

A MULTIPLEXED RNA REGULATION PLATFORM FOR PRIMARY IMMUNE CELL ENGINEERING

#843
US20260053922A1
Human necessities

MULTI-CHAIN SYNTHETIC RECEPTORS FOR SIMULTANEOUS LIGAND-INDUCED TRANSCRIPTIONAL REGULATION AND MEMBRANE-PROXIMAL SIGNAL TRANSDUCTION

#844
US20260053923A1
Human necessities

Immunotherapy of Skeletal Myopathies Using ANTI-FAP CAR-T Cells

#845
US20260053924A1
Human necessities

GENETICALLY ENGINEERED IMMUNE CELLS WITH CHIMERIC RECEPTOR POLYPEPTIDES IN COMBINATION WITH MULTIPLE TRANS METABOLISM MOLECULES AND THERAPEUTIC USES THEREOF

#846
US20260053925A1
Human necessities

DOSING REGIMENS FOR CD19-DIRECTED CANCER IMMUNOTHERAPY

#847
US20260053926A1
Human necessities

PERSONALIZED TOPICAL FORMULATION IMPRINTED WITH QUANTUM ENERGY AND USING AI EXPERT ANALYSIS OPTIMIZATION

#848
US20260053927A1
Human necessities

LOCALIZED RELEASE OF SYSTEMICALLY CIRCULATING THERAPEUTIC SUBSTANCES

#849
US20260053928A1
Human necessities

SYNERGISTIC COMBINATION OF NAD+ AND THERAPEUTIC PEPTIDES DELIVERED VIA IONTOPHORESIS FOR ENHANCED AND PROLONGED REGENERATIVE EFFECTS

#850
US20260053929A1
Human necessities

METAL CHELATING COMPOSITIONS AND METHODS FOR CONTROLLING THE GROWTH OR ACTIVITIES OF A LIVING CELL OR ORGANISM

#851
US20260053930A1
Human necessities

CLINICAL FORMULATIONS

#852
US20260053931A1
Human necessities

MDM2 TARGETING PROTACS

#853
US20260053932A1
Human necessities

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR AND ASSOCIATED METHODS OF USE

#854
US20260053933A1
Human necessities

PROGRAMMABLE NUCLEASE RESISTANCE OF NUCLEIC ACID ASSEMBLIES

#855
US20260053934A1
Human necessities

DUAL ACTION ONLY PROTEOLYSIS TARGETING CHIMERAS AND USES THEREOF

#856
US20260053935A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-BINDING ADJUVANTS

#857
US20260053936A1
Human necessities

IMMUNOGENIC PROTECTIVE ANTIGEN CONJUGATES

#858
US20260053937A1
Human necessities

STEROIDS AND PROTEIN-CONJUGATES THEREOF

#859
US20260053938A1
Human necessities

DIELS-ALDER CONJUGATION METHODS

#860
US20260053939A1
Human necessities

Combination Therapy for Cancer

#861
US20260053940A1
Human necessities

PHARMACEUTICAL COMPOSITION OF ANTIBODY DRUG CONJUGATE

#862
US20260053941A1
Human necessities

MUSCLE TARGETING COMPLEXES AND FORMULATIONS FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

#863
US20260053942A1
Human necessities

STING AGONIST IMMUNOSTIMULATORY ANTIBODY DRUG CONJUGATES

#864
US20260053943A1
Human necessities

NANOCOMPOSITION COMPRISING ANTIBODY-DRUG CONJUGATE AND USE THEREOF

#865
US20260053944A1
Human necessities

CATIONIC PEPTIDE/PROTEIN-MODIFIED EXOSOMES FOR APPLICATIONS IN DRUG DELIVERY

#866
US20260053945A1
Human necessities

GASTROINTESTINAL TRACT STABILIZED PROTEIN DELIVERY USING DISULFIDE TES SYSTEM

#867
US20260053946A1
Human necessities

OXIDIZED CARBON PEG-OAC NANOZYMES FOR MITOCHONDRIAL DISORDERS

#868
US20260053947A1
Human necessities

ADENO-ASSOCIATED VIRUS VARIANT CAPSIDS WITH IMPROVED RETINAL TRANSDUCTION AND USES THEREOF

#869
US20260053948A1
Human necessities

COMPOSITIONS AND METHODS FOR VIROTHERAPY

#870
US20260053949A1
Human necessities

HYBRID AAV CAPSID AND USES THEREOF

#871
US20260053950A1
Human necessities

EPIGENETIC MODULATION OF GENOMIC TARGETS TO CONTROL EXPRESSION OF PWS-ASSOCIATED GENES

#872
US20260053951A1
Human necessities

AAV VECTOR FOR TREATMENT OF FRIEDREICH'S ATAXIA

#873
US20260053952A1
Human necessities

METHODS OF DELIVERING A VIRAL VECTOR TO A KIDNEY

#874
US20260053953A1
Human necessities

USE OF LENTIVIRAL VECTORS EXPRESSING FACTOR VIII

#875
US20260053954A1
Human necessities

Benzaldehyde acetal acid-degradable amphiphilic lipid and self-assembling peptides

#876
US20260053955A1
Human necessities

PRECISE INTEGRATION USING NUCLEASE TARGETED IDLV

#877
US20260053956A1
Human necessities

WATER-SOLUBLE CHLOROPHYLL-BINDING PROTEIN (WSCP)-CHLOROPHYLL COMPLEX AS CONTRAST AGENT FOR PHOTOACOUSTIC IMAGING

#878
US20260053957A1
Human necessities

FREEZE-DRIED NANODROPLETS WITH FLUORINATED COMPOUND

#879
US20260053958A1
Human necessities

HALOGENATED SOMATOSTATIN ANALOGS WITH MULTIPLE SOMATOSTATIN RECEPTOR SUBTYPE SELECTIVITY

#880
US20260053959A1
Human necessities

METHODS FOR LARGE SCALE SYNTHESIS OF RADIONUCLIDE COMPLEXES

#881
US20260053960A1
Human necessities

DIMERIC RADIOPHARMACEUTICALS, COMPOSITIONS THEREOF AND USES THEREOF

#882
US20260053961A1
Human necessities

HETERODIMER AND RADIOACTIVE MEDICAL USE THEREOF

#883
US20260053962A1
Human necessities

Radiopharmaceuticals at Different Activity Reference Times

#884
US20260053963A1
Human necessities

RADIOCONJUGATES TARGETING CD33 IN THE TREATMENT OF BREAST CANCER

#885
US20260053964A1
Human necessities

ULTRAVIOLET-LIGHT-RADIATING DEVICE, AND METHOD FOR CONTROLLING ULTRAVIOLET-LIGHT-RADIATING DEVICE

#886
US20260053965A1
Human necessities

Shoe Sanitization Device

#887
US20260053966A1
Human necessities

MEDICAL OR DENTAL SANITIZING AND/OR MAINTENANCE DEVICE HAVING AN ARTIFICIAL INTELLIGENCE MODULE

#888
US20260053967A1
Human necessities

INTEGRATED MACHINE FOR STERILIZING AND PRESSING, ASSEMBLY LINE FOR STERILIZING AND PRESSING COMBINATION LID AND METHOD THEREFOR

#889
US20260053968A1
Human necessities

MODULAR OIL-CONTROLLED INCENSE DIFFUSER

#890
US20260053969A1
Human necessities

AROMA DIFFUSER

#891
US20260053970A1
Human necessities

AIR STERILISATION UNIT AND METHOD FOR STERILISING AIR

#892
US20260053971A1
Human necessities

STERILIZATION APPARATUS

#893
US20260053972A1
Human necessities

Anti-Microbial Medical Materials and Devices

#894
US20260053973A1
Human necessities

Polymer Composition

#895
US20260053974A1
Human necessities

ADHESIVE FOR AN ABSORBENT ARTICLE

#896
US20260053975A1
Human necessities

MULTI-PUTTY BONE HEMOSTATIC AND ADHESIVE COMPOSITIONS FOR USE IN METHODS OF INSTALLING AND SECURING SURGICAL HARDWARE IN BONES

#897
US20260053976A1
Human necessities

METHACRYLATED METHYLCELLULOSE AND OXIDIZED CARBOXYMETHYLCELLULOSE ADHESIVE HYDROGEL

#898
US20260053977A1
Human necessities

EMBOLIC PARTICLES, METHODS OF FORMING NON-SPHERICAL SHAPED PARTICLES AND METHODS OF USING EMBOLIC PARTICLES TO OCCLUDE A TARGET VESSEL

#899
US20260053978A1
Human necessities

Biodegradable Metallic - Polymeric Composite Prosthesis for Heart Valve Replacement

#900
US20260053979A1
Human necessities

ALIGNED FIBER AND METHOD OF USE THEREOF